Publications by authors named "Maria Teresa Buonanno"
Article Synopsis
- SARS-CoV-2, responsible for COVID-19, poses a higher risk of severe illness for patients with hematological malignancies due to weakened immune systems.
- A study of 106 hematology patients, mainly vaccinated with three or more doses, found 71% had adequate neutralizing antibodies against the original virus, while 82% did for the Omicron BA.1 variant.
- Notably, patients with B-cell disorders or who received anti-CD20 treatments had significantly lower antibody responses, suggesting the need for continued protective measures for these high-risk individuals.
Staging and monitoring of multiple myeloma (MM) is mainly based on monoclonal component quantification; the absence of such a parameter renders difficult follow up of patients with nonsecretory MM (nsMM). In this study our aims were to determine the specificity and sensitivity of Tc99m-sestaMIBI scintigraphy at diagnosis and during follow up of nsMM patients. Nine nsMM patients were prospectively studied at diagnosis and during treatment for a mean time of 33 months (range: 12-65+).
View Article and Find Full Text PDF